Search Results

There are 2859 results for: content related to: The tyrosine kinase inhibitor dasatinib suppresses cytokine production by plasmacytoid dendritic cells by targeting endosomal transport of C p G DNA

  1. You have free access to this content
    Design, Synthesis, and Evaluation of Dasatinib–Amino Acid and Dasatinib–Fatty Acid Conjugates as Protein Tyrosine Kinase Inhibitors


    Volume 12, Issue 1, January 5, 2017, Pages: 86–99, Prof. Rakesh K. Tiwari, Dr. Alex Brown, Dr. Neda Sadeghiani, Dr. Amir Nasrolahi Shirazi, Jared Bolton, Amanda Tse, Prof. Gennady Verkhivker, Prof. Keykavous Parang and Prof. Gongqin Sun

    Version of Record online : 5 DEC 2016, DOI: 10.1002/cmdc.201600387

  2. Phase I Study of the Effect of Gastric Acid pH Modulators on the Bioavailability of Oral Dasatinib in Healthy Subjects

    The Journal of Clinical Pharmacology

    Volume 49, Issue 6, June 2009, Pages: 700–709, Dr Timothy Eley, Dr Feng R. Luo, Dr Shruti Agrawal, Dr Ashish Sanil, Dr James Manning, Dr Tong Li, Dr Anne Blackwood-Chirchir and Dr Richard Bertz

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009333854

  3. You have free access to this content
    Dasatinib inhibits B cell receptor signalling in chronic lymphocytic leukaemia but novel combination approaches are required to overcome additional pro-survival microenvironmental signals

    British Journal of Haematology

    Volume 153, Issue 2, April 2011, Pages: 199–211, Alison M. MCCaig, Emilio Cosimo, Michael T. Leach and Alison M. Michie

    Version of Record online : 24 FEB 2011, DOI: 10.1111/j.1365-2141.2010.08507.x

  4. You have free access to this content
    Phase 1 pharmacokinetic and drug-interaction study of dasatinib in patients with advanced solid tumors


    Volume 116, Issue 6, 15 March 2010, Pages: 1582–1591, Faye M. Johnson, Shruti Agrawal, Howard Burris, Lee Rosen, Navneet Dhillon, David Hong, Anne Blackwood-Chirchir, Feng R. Luo, Oumar Sy, Sanjeev Kaul and Alberto A. Chiappori

    Version of Record online : 27 JAN 2010, DOI: 10.1002/cncr.24927

  5. You have free access to this content
    The impact of dasatinib on pregnancy outcomes

    American Journal of Hematology

    Volume 90, Issue 12, December 2015, Pages: 1111–1115, Jorge E. Cortes, Elisabetta Abruzzese, Ekaterina Chelysheva, Mausumee Guha, Nicola Wallis and Jane F. Apperley

    Version of Record online : 12 OCT 2015, DOI: 10.1002/ajh.24186

  6. You have free access to this content
    Dasatinib inhibits the proliferation and function of CD4+CD25+ regulatory T cells

    British Journal of Haematology

    Volume 144, Issue 2, January 2009, Pages: 195–205, Fei Fei, Yingzhe Yu, Anita Schmitt, Markus Thomas Rojewski, Baoan Chen, Marlies Götz, Hartmut Döhner, Donald Bunjes and Michael Schmitt

    Version of Record online : 11 NOV 2008, DOI: 10.1111/j.1365-2141.2008.07433.x

  7. You have free access to this content
    Dasatinib induces autophagic cell death in human ovarian cancer


    Volume 116, Issue 21, 1 November 2010, Pages: 4980–4990, Xiao-Feng Le, Weiqun Mao, Zhen Lu, Bing Z. Carter and Robert C. Bast Jr

    Version of Record online : 13 JUL 2010, DOI: 10.1002/cncr.25426

  8. You have free access to this content
    Dasatinib treatment for Philadelphia chromosome-positive leukemias


    Volume 115, Issue 7, 1 April 2009, Pages: 1381–1394, Hanna Jean Khoury, François Guilhot, Timothy P. Hughes, Dong-Wook Kim and Jorge E. Cortes

    Version of Record online : 4 FEB 2009, DOI: 10.1002/cncr.24155

  9. You have free access to this content
    Activity of tyrosine kinase inhibitor Dasatinib in neuroblastoma cells in vitro and in orthotopic mouse model

    International Journal of Cancer

    Volume 125, Issue 11, 1 December 2009, Pages: 2547–2555, Roberta Vitali, Camillo Mancini, Vincenzo Cesi, Barbara Tanno, Marta Piscitelli, Mariateresa Mancuso, Fabiola Sesti, Emanuela Pasquali, Bruno Calabretta, Carlo Dominici and Giuseppe Raschellà

    Version of Record online : 28 MAY 2009, DOI: 10.1002/ijc.24606

  10. You have free access to this content
    Inhibition of calcineurin combined with dasatinib has direct and indirect anti-leukemia effects against BCR-ABL1+ leukemia

    American Journal of Hematology

    Volume 89, Issue 9, September 2014, Pages: 896–903, Lori A. Gardner, Jelena Klawitter, Mark A. Gregory, Vadym Zaberezhnyy, Dmitry Baturin, Daniel A. Pollyea, Naoko Takebe, Uwe Christians, Lia Gore, James DeGregori and Christopher C. Porter

    Version of Record online : 19 JUN 2014, DOI: 10.1002/ajh.23776

  11. Dasatinib inhibits mammary tumour development in a genetically engineered mouse model

    The Journal of Pathology

    Volume 230, Issue 4, August 2013, Pages: 430–440, Saadia A Karim, Helen Creedon, Hitesh Patel, Neil O Carragher, Jennifer P Morton, William J Muller, Thomas RJ Evans, Barry Gusterson, Owen J Sansom and Valerie G Brunton

    Version of Record online : 9 JUL 2013, DOI: 10.1002/path.4202

  12. You have free access to this content
    Enhancement of natural killer cell effector functions against selected lymphoma and leukemia cell lines by dasatinib

    International Journal of Cancer

    Volume 131, Issue 6, 15 September 2012, Pages: E916–E927, Nicole Hassold, Katharina Seystahl, Kristina Kempf, Doris Urlaub, Michael Zekl, Hermann Einsele, Carsten Watzl, Jörg Wischhusen and Ruth Seggewiss-Bernhardt

    Version of Record online : 4 APR 2012, DOI: 10.1002/ijc.27537

  13. You have free access to this content
    Bleeding diathesis in patients with chronic myelogenous leukemia receiving dasatinib therapy


    Volume 115, Issue 11, 1 June 2009, Pages: 2482–2490, Alfonso Quintás-Cardama, Hagop Kantarjian, Farhad Ravandi, Susan O'Brien, Deborah Thomas, Gabriela Vidal-Senmache, William Wierda, Steven Kornblau and Jorge Cortes

    Version of Record online : 11 MAR 2009, DOI: 10.1002/cncr.24257

  14. You have full text access to this Open Access content
    Through the open door: Preferential binding of dasatinib to the active form of BCR-ABL unveiled by in silico experiments

    Molecular Oncology

    Volume 7, Issue 5, October 2013, Pages: 968–975, Erik Laurini, Paola Posocco, Maurizio Fermeglia, Don L. Gibbons, Alfonso Quintás-Cardama, Sabrina Pricl

    Version of Record online : 15 JUN 2013, DOI: 10.1016/j.molonc.2013.06.001

  15. You have free access to this content
    The tyrosine kinase inhibitor dasatinib reduces lung inflammation and remodelling in experimental allergic asthma

    British Journal of Pharmacology

    Volume 173, Issue 7, April 2016, Pages: 1236–1247, AL da Silva, RF Magalhães, VC Branco, JD Silva, FF Cruz, PS Marques, TPT Ferreira, MM Morales, MA Martins, PC Olsen and PRM Rocco

    Version of Record online : 25 FEB 2016, DOI: 10.1111/bph.13430

  16. You have free access to this content
    Dynamics and management of cytopenias associated with dasatinib therapy in patients with chronic myeloid leukemia in chronic phase after imatinib failure


    Volume 115, Issue 17, 1 September 2009, Pages: 3935–3943, Alfonso Quintás-Cardama, Fabio Pires De Souza Santos, Hagop Kantarjian, Susan O'Brien, Stefan Faderl, Ahmed Awais, Gautam Borthakur and Jorge Cortes

    Version of Record online : 10 JUN 2009, DOI: 10.1002/cncr.24432

  17. You have full text access to this OnlineOpen article
    Direct effect of dasatinib on signal transduction pathways associated with a rapid mobilization of cytotoxic lymphocytes

    Cancer Medicine

    Volume 5, Issue 11, November 2016, Pages: 3223–3234, Noriyoshi Iriyama, Yoshihiro Hatta and Masami Takei

    Version of Record online : 10 OCT 2016, DOI: 10.1002/cam4.925

  18. You have full text access to this OnlineOpen article
    Dasatinib inhibits actin fiber reorganization and promotes endothelial cell permeability through RhoA-ROCK pathway

    Cancer Medicine

    Volume 6, Issue 4, April 2017, Pages: 809–818, Swapan K. Dasgupta, Anhquyen Le, K. Vinod Vijayan and Perumal Thiagarajan

    Version of Record online : 18 MAR 2017, DOI: 10.1002/cam4.1019

  19. You have free access to this content
    Ingredients in Fruit Juices Interact with Dasatinib Through Inhibition of BCRP: A New Mechanism of Beverage–Drug Interaction

    Journal of Pharmaceutical Sciences

    Volume 104, Issue 1, January 2015, Pages: 266–275, Brett Fleisher, Jesse Unum, Jie Shao and Guohua An

    Version of Record online : 21 NOV 2014, DOI: 10.1002/jps.24289

  20. You have full text access to this Open Access content
    The chemokine interleukin-8 and the surface activation protein CD69 are markers for Bcr–Abl activity in chronic myeloid leukemia

    Molecular Oncology

    Volume 2, Issue 3, October 2008, Pages: 272–281, Oliver Hantschel, Agnes Gstoettenbauer, Jacques Colinge, Ines Kaupe, Martin Bilban, Thomas R. Burkard, Peter Valent, Giulio Superti-Furga

    Version of Record online : 23 JUL 2008, DOI: 10.1016/j.molonc.2008.07.003